Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Silo Pharma Inc
SILOCurrent price
1.18 USD
+0.01 USD (+0.85%)
Last closed
1.13 USD
Company
silopharma.com
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
OTCQB
Capitalization
4 708 683 USD
Yield for 12 month
-23.87 %
1Y
3Y
5Y
10Y
15Y
SILO
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida. Address: 677 N. Washington Boulevard, Sarasota, FL, United States, 34236
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
10 USDP/E ratio
–Dividend Yield
–Current Year
+72 102 USD
Last Year
+72 102 USD
Current Quarter
+18 025 USD
Last Quarter
+18 026 USD
Current Year
-805 361 USD
Last Year
+66 264 USD
Current Quarter
+16 566 USD
Last Quarter
+16 566 USD
Key Figures SILO
1 year
3 years
5 years
10 years
EBITDA
–
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-26.11 %
PEG Ratio
–
Return On Equity TTM
-48.34 %
Wall Street Target Price
10 USD
Revenue TTM
72 102 USD
Book Value
1.6 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
66 260 USD
Earnings per share
-1.16 USD
Diluted Eps TTM
-1.16 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics SILO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SILO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:50
Payout Ratio
–
Last Split Date
15.09.2022
Dividend Date
–
Stock Valuation SILO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
9.7095
Price Sales TTM
65.3059
Enterprise Value EBITDA
0.5619
Price Book MRQ
0.7903
Financials SILO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SILO
For 52 weeks
0.84 USD
4.5 USD
50 Day MA
1.13 USD
Shares Short Prior Month
134 766
200 Day MA
1.52 USD
Short Ratio
1.87
Shares Short
67 438
Short Percent
3.01 %
BeatStart